Site Search
Search Results
Improving Access to Biomarker Testing
The knowledge and practice of precision medicine in cancer have been progressing rapidly and advances have led to targeted cancer therapies that can improve patient survival and quality life. Treatment with targeted therapy often requires diagnostic testing to analyze biological samples ... clinical use does not always follow, and testing rates lag behind clinical guideline recommendations. As highlighted in a recent ACS CAN survey of cancer patients and survivors, only one-third of respondents reported having biomarker testing. Of those who reported not receiving biomarker ...
Priority Issue
State
Policy Issue
- (-) Remove Research, Funding and Drug Development filter Research, Funding and Drug Development